Bio-Techne Corp
SWB:TE1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bio-Techne Corp
SWB:TE1
|
US |
|
Promotora y Operadora de Infraestructura SAB de CV
BMV:PINFRAL
|
MX |
|
T
|
Take-Two Interactive Software Inc
XMUN:TKE
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
SGS SA
F:SUV
|
CH |
Wall St Price Targets
TE1 Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for TE1 is 61.57 EUR with a low forecast of 42.97 EUR and a high forecast of 70.58 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TE1's stock price target?
Price Target
61.57
EUR
According to Wall Street analysts, the average 1-year price target for TE1 is 61.57 EUR with a low forecast of 42.97 EUR and a high forecast of 70.58 EUR.
What is the Revenue forecast for Bio-Techne Corp?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Bio-Techne Corp?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 4 years is 9%.
What is the Operating Income forecast for Bio-Techne Corp?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 4 years is 19%.
What is the Pre-Tax Income forecast for Bio-Techne Corp?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 32%.
What is the Net Income forecast for Bio-Techne Corp?
Projected CAGR
25%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 4 years is 25%.
